Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v7-FR Version v1-EN
Language French English
Date Updated 2020-01-30 2019-11-28
Drug Identification Number 02454300 02454300
Brand name ACT ESCITALOPRAM ODT ACT ESCITALOPRAM ODT
Common or Proper name ACT ESCITALOPRAM 20MG OD TAB ACT ESCITALOPRAM 20MG OD TAB
Company Name TEVA CANADA LIMITED TEVA CANADA LIMITED
Ingredients ESCITALOPRAM ESCITALOPRAM
Strength(s) 20MG 20MG
Dosage form(s) TABLET (ORALLY DISINTEGRATING) TABLET (ORALLY DISINTEGRATING)
Route of administration ORAL ORAL
Packaging size 30UD 30UD
ATC code N06AB N06AB
ATC description ANTIDEPRESSANTS ANTIDEPRESSANTS
Reason for shortage Disruption of the manufacture of the drug. Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2019-11-28 2019-11-28
Estimated end date 2020-02-29 2019-12-31
Actual end date
Shortage status Actual shortage Anticipated shortage
Tier 3 Status No No
Company comments
Health Canada comments